IOVA   $10.15  -2.07% Market Closed After Close 10.15 0.0

Iovance Biotherapeutics Inc
Total Cash 412.54M
totalCashPerShare 1.359
EBITDA -439.25M
Total Debt 81.68M
quickRatio 4.743
currentRatio 5.15
Total Revenue 32.77M
debtToEquity 10.628
Revenue/Share 0.124
ROA -0.33345002
ROE -0.65357
grossProfits
freeCashflow -221.83M
operatingCashflow -388.76M
earningsGrowth
revenueGrowth 129.697
grossMargins -0.44434
ebitdaMargins 0.0
operatingMargins -3.27635
profitMargins 0.0
enterpriseValue 2.81B
forwardPE -14.361111
floatShares 224.32M
sharesOutstanding 303.51M
sharesShort 57.69M
sharesShortPriorMonth 61.32M
dateShortInterest
sharesPercentSharesOut 0.19%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.87%
Short Ratio help_outline 7.85%
shortPercentOfFloat 0.21%
impliedSharesOutstanding
bookValue 2.585
Price To Book help_outline 4.00
earningsQuarterlyGrowth
netIncomeToCommon -440.22M
trailingEps -1.67%
forwardEps -0.72%
enterpriseToEbitda -6.39
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.3 3Q 2024
institutionsCount 393
lastUpdated Sept. 16, 2024, 12:45 p.m.